Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Robert J. Torphy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3941-0886; OpenAlex author ID A5009029114. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 3 papers · 2025: 2 papers

Papers 15

  1. Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.70088↗
  2. Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First. Co-author DOI 10.1200/edbk-25-473204↗
  3. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study. Co-author DOI 10.1097/sla.0000000000005925↗
  4. Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemothera… First author DOI 10.1245/s10434-024-15443-1↗
  5. Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection. First author DOI 10.1245/s10434-024-15975-6↗
  6. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Co-author DOI 10.1097/sla.0000000000003859↗
  7. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreati… Co-author DOI 10.1016/j.hpb.2020.11.004↗
  8. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy. Co-author DOI 10.1002/mc.23179↗
  9. Pancreatic cancer treatment: better, but a long way to go. Co-author DOI 10.1007/s00595-020-02028-0↗
  10. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. First author DOI 10.1172/jci136760↗
  11. Immunotherapy for pancreatic cancer: Barriers and breakthroughs. Co-author DOI 10.1002/ags3.12176↗
  12. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? Co-author DOI 10.1016/j.suc.2017.09.003↗
  13. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1200/po.17.00121↗
  14. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma. Co-author DOI 10.1371/journal.pone.0089474↗
  15. Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer. Co-author DOI 10.1021/ac401720k↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard David Schulick · 9 shared papers, 2018–2024 · strength 1.54
  2. Toshitaka Sugawara · 3 shared papers, 2024 · strength 0.58
  3. Oskar Franklin · 3 shared papers, 2024 · strength 0.58
  4. Kevin C. Soares · 2 shared papers, 2025 · strength 0.57
  5. Martin M. McCarter · 2 shared papers, 2024 · strength 0.39
  6. Marco Del Chiaro · 2 shared papers, 2024 · strength 0.39
  7. Elliott J. Yee · 2 shared papers, 2024 · strength 0.39
  8. Bishal Gyawali · 1 shared paper, 2025 · strength 0.37
  9. Kim A. Reiss · 1 shared paper, 2025 · strength 0.37
  10. Ana Gleisner · 2 shared papers, 2022–2024 · strength 0.35
  11. Yuwen Zhu · 2 shared papers, 2018–2020 · strength 0.32
  12. Marco Del Chiaro · 2 shared papers, 2021–2024 · strength 0.32
  13. Jen Jen Yeh · 4 shared papers, 2013–2020 · strength 0.24
  14. Vinod P. Balachandran · 1 shared paper, 2025 · strength 0.21
  15. Sean James Judge · 1 shared paper, 2025 · strength 0.21
  16. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.21
  17. Caitlin A. McIntyre · 1 shared paper, 2025 · strength 0.21
  18. Wungki Park · 1 shared paper, 2025 · strength 0.21
  19. Eileen Mary O'Reilly · 1 shared paper, 2025 · strength 0.21
  20. Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.21
  21. William R. Jarnagin · 1 shared paper, 2025 · strength 0.21
  22. T. Peter Kingham · 1 shared paper, 2025 · strength 0.21
  23. Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.21
  24. Jun Ishida · 1 shared paper, 2024 · strength 0.20
  25. Samuele Grandi · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.